Dr David R Fischler, MD - Medicare Pulmonary Disease in East Brunswick, NJ

Dr David R Fischler, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in East Brunswick, New Jersey. He went to Albert Einstein College Of Medicine Of Yeshiva University and graduated in 1998 and has 26 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Robert Wood Johnson Physician Enterprise, Pulmonary And Intensive Care Specialists Of New Jersey and his current practice location is 593 Cranbury Rd, Suite 1a, East Brunswick, New Jersey. You can reach out to his office (for appointments etc.) via phone at (732) 613-8880.

Dr David R Fischler is licensed to practice in New Jersey (license number 25MA07725700) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1275622540.

Contact Information

Dr David R Fischler, MD
593 Cranbury Rd, Suite 1a,
East Brunswick, NJ 08816-4029
(732) 613-8880
(732) 613-0077



Physician's Profile

Full NameDr David R Fischler
GenderMale
SpecialityPulmonary Disease
Experience26 Years
Location593 Cranbury Rd, East Brunswick, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr David R Fischler attended and graduated from Albert Einstein College Of Medicine Of Yeshiva University in 1998
  NPI Data:
  • NPI Number: 1275622540
  • Provider Enumeration Date: 10/12/2006
  • Last Update Date: 04/26/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 9032182696
  • Enrollment ID: I20040813000080

Medical Identifiers

Medical identifiers for Dr David R Fischler such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1275622540NPI-NPPES
0103241MedicaidNJ
02720212OtherNYNY MEDICAID

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine 25MA07725700 (New Jersey)Secondary
207RC0200XInternal Medicine - Critical Care Medicine 25MA07725700 (New Jersey)Secondary
207RP1001XInternal Medicine - Pulmonary Disease 25MA07725700 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Robert Wood Johnson University HospitalNew brunswick, NJHospital
Saint Peter's University HospitalNew brunswick, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Robert Wood Johnson Physician Enterprise559791763347
Pulmonary And Intensive Care Specialists Of New Jersey62047256177

News Archive

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.

University of Kaiserslautern uses JPK NanoWizard AFM to study bacterial interaction with microstructured surfaces

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research into the interaction of bacteria with microstructured surfaces in the Department of Physics at the University of Kaiserslautern in Germany.

Concerns over the privacy of patients could be hampering efforts to spot disease clusters

...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

Face mask sewing related to well-being at start of pandemic

During a critical face mask shortage at the start of the COVID-19 pandemic, home sewers responded by pulling out fabric stashes, threading their machines and getting to work.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr David R Fischler allows following entities to bill medicare on his behalf.
Entity NamePulmonary And Intensive Care Specialists Of New Jersey
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366531634
PECOS PAC ID: 6204725617
Enrollment ID: O20040313000106

News Archive

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.

University of Kaiserslautern uses JPK NanoWizard AFM to study bacterial interaction with microstructured surfaces

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research into the interaction of bacteria with microstructured surfaces in the Department of Physics at the University of Kaiserslautern in Germany.

Concerns over the privacy of patients could be hampering efforts to spot disease clusters

...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

Face mask sewing related to well-being at start of pandemic

During a critical face mask shortage at the start of the COVID-19 pandemic, home sewers responded by pulling out fabric stashes, threading their machines and getting to work.

Read more Medical News

› Verified 6 days ago

Entity NameRobert Wood Johnson Physician Enterprise
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245587922
PECOS PAC ID: 5597917633
Enrollment ID: O20121218000345

News Archive

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.

University of Kaiserslautern uses JPK NanoWizard AFM to study bacterial interaction with microstructured surfaces

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research into the interaction of bacteria with microstructured surfaces in the Department of Physics at the University of Kaiserslautern in Germany.

Concerns over the privacy of patients could be hampering efforts to spot disease clusters

...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

Face mask sewing related to well-being at start of pandemic

During a critical face mask shortage at the start of the COVID-19 pandemic, home sewers responded by pulling out fabric stashes, threading their machines and getting to work.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David R Fischler is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr David R Fischler, MD
593 Cranbury Rd, Suite 1a,
East Brunswick, NJ 08816-4029

Ph: (732) 613-8880
Dr David R Fischler, MD
593 Cranbury Rd, Suite 1a,
East Brunswick, NJ 08816-4029

Ph: (732) 613-8880

News Archive

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.

University of Kaiserslautern uses JPK NanoWizard AFM to study bacterial interaction with microstructured surfaces

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research into the interaction of bacteria with microstructured surfaces in the Department of Physics at the University of Kaiserslautern in Germany.

Concerns over the privacy of patients could be hampering efforts to spot disease clusters

...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

Face mask sewing related to well-being at start of pandemic

During a critical face mask shortage at the start of the COVID-19 pandemic, home sewers responded by pulling out fabric stashes, threading their machines and getting to work.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in East Brunswick, NJ

Ellen A Ronnen, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 629 Cranbury Rd Fl 2, East Brunswick, NJ 08816
Phone: 732-390-7750    Fax: 732-390-7725
Dr. Alan Sheldon Lichtbroun, M.D.
Pulmonary Disease
Medicare: Medicare Enrolled
Practice Location: 63 Brunswick Woods Dr, East Brunswick, NJ 08816
Phone: 732-613-1900    Fax: 732-613-0029
Dr. Francis C D'mello, M.D.
Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: 385 State Route 18, West Ferris Plaza Unit K, East Brunswick, NJ 08816
Phone: 732-238-4343    Fax: 732-238-6981
Dr. Jose C Costa, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 465 Cranbury Rd, Suite 102, East Brunswick, NJ 08816
Phone: 732-390-1995    Fax: 732-254-4610
Dr. Mervat B Mansour, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 2 Auer Ct Ste D, East Brunswick, NJ 08816
Phone: 732-257-5530    Fax: 732-257-5531
Dr. Marsha Kallich, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 579a Cranbury Rd, Suite 102, East Brunswick, NJ 08816
Phone: 732-613-0711    Fax: 732-613-5783
Raafat Ghobraiel, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 79 Brunswick Woods Dr, East Brunswick, NJ 08816
Phone: 732-254-7778    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.